|
[1]Fabrizi F, Martin P, Dixit V, et al. Acquisition of hepatitis C virus in hemodialysis patients: a prospective study by branched DNA signal amplification assay[J].Am J Kidney Dis, 1998, 31∶647-54.
|
|
[2]Furusyo N, Hayashi J, Kakuda K, et al. Acute hepatitis C among Japanese hemodialysis patients: a prospective 9-year study [J]. Am J Gastroenterol, 2001, 96∶1593-1600.
|
|
[3]Schneeberger PM, Keur I, Van der Vliet W, et al. Hepatitis C virus infection in dialysis centers in The Netherlands: a national survey by serological and molecular methods[J]. J Clin Microbiol, 1998, 36∶1711.
|
|
[4]Arenas MD, Munoz C, Sanchoz-Paya J, et al. Destruction of hepatitis C virus genotypes among the hemodialysis population in the province of Alicante [J]. Nefrologia, 2001, 21 (6) ∶581-7.
|
|
[5]Nakayama E, Akiba T, Marumo F, et al. Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy[J]. J Am Soc Nephrol, 2000, 11∶1896-1902.
|
|
[6]Toz H, Ok E, Yilmaz F, et al. Clinicopathological features of hepatitis C virus infection in dialysis and renal transplantation[J]. J Nephrol, 2002, 15 (3) ∶308-12.
|
|
[7]Isopet J, Rostaing L, Sandres K, et al. Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients[J]. J Infect Dis, 2000, 181∶852-58.
|
|
[8]Mathurin P, Mouquer C, Poynard T, et al. Impact of hepatitis B and C virus on kidney transplantation outcome[J]. Hepatology 1999, 29∶257.
|
|
[9]Hanafusa T, Ichikawa Y, Kishikawa H, et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years[J]. Transplantation, 1998, 66∶471-76.
|
|
[10]Hou TI, Yang WC, Wu JC, et al. Long-term outcome of kidney transplantation in patients with hepatisis C virus infection[J]. Hepatogastroenterology, 2001, 48 (37) ∶169-73.
|
|
[11]Ali MK, Light JA, Barhyte DY, et al. Donor hepatisis virus status does not adversely affect short-term outcomes in HCV positive recipients in renal transplantation[J]. Transplantation 1998, 66∶1694-97.
|
|
[12]Bruchfeld A, Stahle L, Andersson J, et al. Ribavirin treatment in dialysis patients with chronic hepatisis C virus infection-α pilot study[J]. J Viral Hep, 2001, 8∶287-92.
|
|
[13]Rostaing L. Treatment of hepatitis C virus infection after renal transplantation: new insights[J]. Nephrol Dial Transplant, 2000, 15 (suppl8) ∶74-76.
|
|
[14] Martin P, Mitra S, Farrington K, et al. Pegylated (40KDA) interferon alfa-2a (PegasysTM) is affected by renal impairment [Absract][J]. Hepatology, 2000, 32 (part 2) ∶842.
|
PDF下载 ( 119 KB)
本文二维码
下载:
